Clinical Roundup City of Hope and TGen research reveals potential cause of aggressive leukemia October 13, 2023Vol.49 No.38
Clinical Roundup New antibody shows strong potential against pancreatic cancer October 13, 2023Vol.49 No.38
Clinical Roundup NYU Perlmutter research suggests drug combination could starve pancreatic cancer October 13, 2023Vol.49 No.38
Clinical Roundup Telomere-targeting agent demonstrates potent anticancer activity in aggressive pediatric brain cancer in preclinical study October 13, 2023Vol.49 No.38
Clinical Roundup NCCN: U.S. cancer centers continue to see chemotherapy shortages October 06, 2023Vol.49 No.37
Clinical Roundup ASCO issues recommendations for assessing ovarian toxicity in cancer clinical trials October 06, 2023Vol.49 No.37
Clinical Roundup Fox Chase study demonstrates how amplification and rearrangement of MLL gene is controlled by epigenetic factors October 06, 2023Vol.49 No.37
Clinical Roundup City of Hope opens first U.S. multicenter clinical trial for robotic single-port mastectomies for breast cancer patients October 06, 2023Vol.49 No.37
Clinical Roundup Cancer drug targets uncovered using base editing and chemical proteomics October 06, 2023Vol.49 No.37
Clinical Roundup Phase III Mariposa study evaluating Rybrevant + lazertinib meets primary endpoint in PFS in NSCLC September 29, 2023Vol.49 No.36
